Cargando…

Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action

Detalles Bibliográficos
Autores principales:	Choudhary, Om Prakash, Dhawan, Manish, Priyanka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656212/ https://www.ncbi.nlm.nih.gov/pubmed/34896627 http://dx.doi.org/10.1016/j.ijsu.2021.106187

Ejemplares similares

Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions
por: Islam, Fahadul, et al.
Publicado: (2022)

Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
por: Chavda, Vivek P, et al.
Publicado: (2022)

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
por: Rahmani, Shayan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape
por: Sanyaolu, Adekunle, et al.
Publicado: (2022)

Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater
por: Ahmed, Warish, et al.
Publicado: (2022)

First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador
por: Carrazco-Montalvo, A., et al.
Publicado: (2022)

The rapid replacement of the Delta variant by Omicron (B.1.1.529) in England
por: Paton, Robert S., et al.
Publicado: (2022)

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
por: Chun, June Young, et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt
por: Dhawan, Manish, et al.
Publicado: (2022)

SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection
por: Elkoshi, Zeev
Publicado: (2022)

SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2023)

SARS-CoV-2 (B1.1.529) Omicron variant: what has changed in the nose?
por: Ciurkiewicz, M., et al.
Publicado: (2023)

Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
por: Dhawan, Manish, et al.
Publicado: (2022)

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
por: Andrews, Nick, et al.
Publicado: (2022)

A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
por: Manjunath, R, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Omicron variant (B.1.1.529) infection of white-tailed deer
por: Vandegrift, Kurt J., et al.
Publicado: (2022)

The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2022)

Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance
por: Ren, Shi-Yan, et al.
Publicado: (2022)

The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals
por: Sánchez-Morales, Lidia, et al.
Publicado: (2022)

Fractional order mathematical model for B.1.1.529 SARS-Cov-2 Omicron variant with quarantine and vaccination
por: Dickson, S., et al.
Publicado: (2023)

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021
Publicado: (2021)

The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic
por: Ri, HyokJu, et al.
Publicado: (2022)

Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients
por: Spensley, Katrina J., et al.
Publicado: (2022)

The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
por: Sheward, Daniel J, et al.
Publicado: (2022)

Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
por: Lee, Ji Joo, et al.
Publicado: (2021)

Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing
por: Rasmussen, Lasse D., et al.
Publicado: (2022)

Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
por: Rabiul Islam, Md., et al.
Publicado: (2022)

Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
por: Ren, Wenlin, et al.
Publicado: (2023)

Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021)

Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
por: Grüne, Barbara, et al.
Publicado: (2022)

Omicron B.1.1.529 subvariant: Brief evidence and future prospects
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Clinical Characteristics of Omicron (B.1.1.529) Variant in Children: A Multicenter Study in Spain
por: Molina Gutiérrez, Miguel Ángel, et al.
Publicado: (2022)

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
por: Reynolds, Catherine J., et al.
Publicado: (2022)

A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
por: Lu, Yuying, et al.
Publicado: (2023)

Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa
por: Nishiura, Hiroshi, et al.
Publicado: (2021)

Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland
por: Lorthe, Elsa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b0mnouirjfhvthgc38mo4737to